Meng Xia

Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.

X. Liao, Yibin Wang, Hongliang Li, 2020, Hypertension.

Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19

P. Ye, R. Touyz, G. Akolkar, 2020, Hypertension.

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Qingbo Xu, J. Xie, P. Ye, 2020, Circulation research.

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Qingbo Xu, P. Ye, Yibin Wang, 2020, Cell Metabolism.

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

P. Ye, Yibin Wang, Jingjing Cai, 2020, Cell Metabolism.